Literature DB >> 16343232

Role of conservative surgery in ovarian cancer: the European experience.

N Colombo1, G Parma, M T Lapresa, F Maggi, P Piantanida, A Maggioni.   

Abstract

Although less frequently than in older women, about 15% of invasive epithelial ovarian cancer may occur in young women, for whom preservation of fertility potential is an important clinical goal. We reviewed the published evidences from the European literature on the role of conservative surgery in women with invasive epithelial ovarian cancer. Three reports were identified from the Italian and French literature; the data were analyzed together with our own experience in terms of relapse rate, relapse in the preserved ovary, survival, and fertility outcome. A total of 152 conservative surgeries were reported: 88 patients with stage IA, 2 with stage IB, 51 with stage IC, 2 with stage II, 3 with stage IIIA, and 6 with stage IIIC. Relapses occurred in 18/152 patients (11.8%) and involved the preserved ovary in 11 cases (7%). Fifty-three pregnancies were recorded with 38 uneventful term deliveries, 2 ectopic pregnancies, 6 spontaneous abortions, 4 terminations, and 2 with unknown outcome. Nine patients (5.9%) have died of disease. These findings confirm that young women with stage I invasive epithelial ovarian cancer may receive a successful treatment of their disease without sacrificing fertility.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16343232     DOI: 10.1111/j.1525-1438.2005.00428.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  9 in total

1.  S3-Guideline on Diagnostics, Therapy and Follow-up of Malignant Ovarian Tumours: Short version 1.0 - AWMF registration number: 032/035OL, June 2013.

Authors:  U Wagner; P Harter; F Hilpert; S Mahner; A Reuß; A du Bois; E Petru; W Meier; P Ortner; K König; K Lindel; D Grab; P Piso; O Ortmann; I Runnebaum; J Pfisterer; D Lüftner; N Frickhofen; F Grünwald; B O Maier; J Diebold; S Hauptmann; F Kommoss; G Emons; B Radeleff; M Gebhardt; N Arnold; G Calaminus; I Weisse; J Weis; J Sehouli; D Fink; A Burges; A Hasenburg; C Eggert
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-09       Impact factor: 2.915

Review 2.  Fertility preserving options in patients with gynecologic malignancies.

Authors:  Ramez N Eskander; Leslie M Randall; Michael L Berman; Krishnansu S Tewari; Philip J Disaia; Robert E Bristow
Journal:  Am J Obstet Gynecol       Date:  2011-03-16       Impact factor: 8.661

Review 3.  Quality-of-life issues in the management of epithelial ovarian cancer.

Authors:  Thomas Lowe; Betty Ferrell; Lucille Leong
Journal:  Curr Treat Options Oncol       Date:  2007-12

4.  Results of Fertility-Sparing Surgery for Expansile and Infiltrative Mucinous Ovarian Cancers.

Authors:  Sebastien Gouy; Marine Saidani; Amandine Maulard; Slim Bach-Hamba; Enrica Bentivegna; Alexandra Leary; Patricia Pautier; Mojgan Devouassoux-Shisheboran; Catherine Genestie; Philippe Morice
Journal:  Oncologist       Date:  2017-12-14

5.  Medical and psychosocial aspects of fertility after cancer.

Authors:  Christine Duffy; Susan Allen
Journal:  Cancer J       Date:  2009 Jan-Feb       Impact factor: 3.360

Review 6.  Fertility preservation in gynecological cancers.

Authors:  Shakuntala Chhabra; Imran Kutchi
Journal:  Clin Med Insights Reprod Health       Date:  2013-03-21

Review 7.  Building a successful fertility preservation program at a major cancer center.

Authors:  Jayeon Kim; Kenneth H Kim; Jennifer E Mersereau
Journal:  J Gynecol Oncol       Date:  2014-04-09       Impact factor: 4.401

Review 8.  Fertility sparing surgery in early stage epithelial ovarian cancer.

Authors:  Antonino Ditto; Fabio Martinelli; Domenica Lorusso; Edward Haeusler; Marialuisa Carcangiu; Francesco Raspagliesi
Journal:  J Gynecol Oncol       Date:  2014-06-18       Impact factor: 4.401

Review 9.  Preservation of ovarian function during chemotherapy and radiotherapy in young women with malignancies.

Authors:  Maryam Eftekhar; Soheila Pourmasumi; Mojgan Karimi-Zarchi
Journal:  Iran J Reprod Med       Date:  2014-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.